DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: A case-control study

World Journal of Gastroenterology

Volumn 13, Issue 45, 2007, Pages 6082-6086

  Wu, Ying ^a   Lin, Ju Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DNA methyltransferase; Primary hepatocellular carcinoma; Single nucleotide polymorphism; Susceptibility

Indexed keywords

CYTOSINE; DNA METHYLTRANSFERASE 3B; THYMINE;

ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CIGARETTE SMOKING; CORRELATION ANALYSIS; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 36949033841     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.13.6082     Document Type: Article

References (32)

1. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
2. Vaniushin BF. DNA methylation and epigenetics. Genetika 2006; 42: 1186-1199
3. Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med 2007; 7: 85-102
4. Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005; 10: 631-647
5. Siedlecki P, Zielenkiewicz P. Mammalian DNA methyltransferases. Acta Biochim Pol 2006; 53: 245-256
6. Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001; 20: 3139-3155
7. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002; 196: 1-7
8. Szyf M. Targeting DNA methylation in cancer. Bull Cancer 2006; 93: 961-972
9. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2007; 96 Suppl: R26-R30
10. Yoshikawa H. DNA methylation and cancer. Gan To Kagaku Ryoho 2007; 34:145-149
11. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775:138-162
12. Kondo Y, Shen L, Suzuki S, Kurokawa T, Masuko K, Tanaka Y, Kato H, Mizuno Y, Yokoe M, Sugauchi F, Hirashima N, Orito E, Osada H, Ueda R, Guo Y, Chen X, Issa JP, Sekido Y. Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res 2007; 37:974-983
13. Eng C, Herman JG, Baylin SB. A bird's eye view of global methylation. Nat Genet 2000; 24: 101-102
14. Jair KW, Bachman KE, Suzuki H, Ting AH, Rhee L Yen RW, Baylin SB, Schuebel KE. De novo CpG island methylation in human cancer cells. Cancer Res 2006; 66: 682-692
15. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27: 2291-2298
16. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF. Genome-wide hypornethylation in hepatocellular carcinogenesis. Cancer Res 2001; 61: 4238-4243
17. Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol 2005; 96: 531-538
18. Park HJ, Yu E, Shim YH. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Cancer Lett 2006; 233: 271-278
19. Schmidt WM, Sedivy R, Forstner B, Steger GG, Zochbauer-Muller S, Mader RM. Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol Carcinog 2007; 46: 766-772
20. Oh BK, Kim H, Park H), Shim YH, Choi J, Park C, Park YN. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med 2007; 20: 65-73
21. Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 2002; 62: 4992-4995
22. Wang L, Rodriguez M, Kim ES, Xu Y, Bekele N, EI-Naggar AK, Hong WK, Mao L, Oh YW. A novel C/T polymorphism. in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int J Oncol 2004; 25: 993-999
23. Montgomery KG, Liu MC, Eccles DM, Campbell IG. The DNMT3B C->T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 2004; 6: R390-R394
24. Jones JS, Amos CI, Pande M, Gu X, Chen J, Campos IM, Wei Q, Rodriguez-Bigas M, Lynch PM, Frazier ML. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev 2006; 15: 886-891
25. Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 2000; 16: 663-676
26. Soejima H, Zhao W, Mukai T. Epigenetic silencing of the MGMT gene in cancer. Biochem Cell Biol 2005; 83:429-437
27. Tannapfel A. Methylation and other new concepts for the origin of hepatocellular carcinoma. Pathologe 2006; 27: 284-288
28. Majumder S, Ghoshal K, Datta J, Smith DS, Bai S, Jacob ST. Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription. J Biol Chem 2006; 281: 22062-22072
29. Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT, Wang YC. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 2007; 55: 205-213
30. Wang YM, Wang R, Wen DG, Li Y, Guo W, Wang N, Wei LZ, He YT, Chen ZF, Zhang XF, Zhang JH. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. World J Gastroenterol 2005; 11: 3623-3627
31. Aung PP, Matsumura S, Kuraoka K, Kunimitsu K, Yoshida K, Matsusaki K, Nakayama H, Yasui W. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 2005; 14:1151-1154
32. Kanai Y, Saito Y, Ushijima S, Hirohashi S. Alterations in gene expression associated with the overexpression of a splice variant of DNA methyltransferase 3b, DNMI3b4, during human hepatocarcinogenesis. J Cancer Res Clin Oncol 2004; 130: 636-644